S 3162
116th Congress
Senate
Health
Competition and antitrust
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Federal officials
Government employee pay, benefits, personnel management
Health care costs and insurance
Health care coverage and access
Health care quality
Health programs administration and funding
Inflation and prices
Licensing and registrations
Manufacturing
Prescription drugs
Public contracts and procurement
Public participation and lobbying
Affordable Drug Manufacturing Act of 2020
Introduced: January 8, 2020
Introduced by:
Warren, Elizabeth
Democratic
· Massachusetts
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 8, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 8, 2020
Introduced in Senate
Plain-English summary
Affordable Drug Manufacturing Act of 2020
This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1